Scandinavian Tobacco Group reported that net sales for the first quarter of 2024 were 1.95 billion Danish Kroner (approximately 281.97 million US dollars), a 1% decrease compared to the same period in 2023. When calculated by the organic growth rate, net sales decreased by 2%.
The organic net sales growth of the company's handmade cigars and next-generation oral care products categories was offset by the decline in machine-made cigars and smoking tobacco. According to the company, the EBITDA profit margin was affected by a decrease in sales volumes in the seasonal small quarter, mix changes, and growth investments.
The group is expected to achieve organic net sales growth and substantial improvement in EBITDA profit margin in the second quarter, while maintaining its full-year guidance.
"Despite the impact of a mix of factors including cost inflation and growth investments on profitability in the early part of the year and the first quarter, we are still maintaining our expectations for the full year," said CEO Niels Frederiksen in a statement.
As we enter the second quarter, we expect improved growth in net sales. We anticipate a more normalized mix which will have a positive impact on profitability and cash flow. During this quarter, we continued to execute our strategy by opening three Macanudo concept stores and investing in our growth plan. Our growth drivers accounted for approximately 11% of net sales for this quarter.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
